Related by context. Frequent words. (Click for all words.) 62 antihypertensive drugs 62 coronary revascularization 61 randomized trials 61 subgroup analyzes 61 RCTs 61 placebo controlled trials 61 randomized clinical trials 61 active comparator 60 DASH diet 60 antihypertensive medications 60 nesiritide 60 substudy 59 HbA1c levels 59 randomized controlled trials 59 candesartan 59 multicenter randomized 59 noninferiority 59 lipid lowering drugs 58 stable angina 58 placebo controlled studies 58 epidemiologic studies 57 warfarin therapy 57 cystatin C 57 observational studies 57 retrospective cohort study 57 randomized clinical 57 Lp PLA2 57 echocardiographic 57 thrombolytic therapy 57 meta analyzes 57 multicentre 57 hypertensive patients 57 multicenter clinical 57 prospective randomized controlled 57 cardiovascular morbidity 57 donepezil 56 rosuvastatin 56 D dimer 56 longitudinal studies 56 randomized controlled trial 56 perindopril 56 left ventricular dysfunction 56 oral glucose tolerance 56 neoadjuvant 56 composite endpoint 56 endarterectomy 56 elevated triglycerides 55 coronary angiography 55 angiotensin receptor blockers 55 Secondary endpoints 55 phase IIa 55 statin therapy 55 placebo controlled randomized 55 COPAXONE R 55 glomerular filtration rate 55 unfractionated heparin 55 microalbuminuria 55 nephrectomy 55 prospective observational 55 virologic failure 55 observational study 55 lipid profiles 55 blinded placebo controlled 55 prospective cohort 55 peginterferon 55 randomized controlled clinical 55 multicenter study 55 randomized 55 myocardial infarctions 55 hsCRP 55 SPIRIT III 55 hs CRP 55 creatinine clearance 54 CYP#C# [001] 54 serum cholesterol 54 citalopram 54 hypercholesterolemia 54 cardiac dysfunction 54 valsartan 54 lamotrigine 54 prespecified 54 hemoglobin A1C 54 impaired fasting glucose 54 fasting insulin 54 hemoglobin A1c 54 randomized controlled 54 blind randomized controlled 54 meta analysis 54 carotid stenting 54 fasting glucose 53 NYHA class 53 dose regimens 53 telmisartan 53 LVEF 53 tocilizumab 53 losartan 53 infarct size 53 pravastatin 53 renal dysfunction 53 logistic regression 53 secondary efficacy endpoints